(Q37071422)

18 August 2017

Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women (English)

1 reference

18 August 2017

1 reference

3

1 reference

18 August 2017

Adalberto Cavalleri

9

0 references

Elisabetta Venturelli

Elisabetta Venturelli

6

0 references

Andrea Micheli

Andrea Micheli

5

0 references

Sabina Sieri

Sabina Sieri

7

0 references

Eva Schernhammer

Eva S Schernhammer

1

0 references

Holger Schünemann

10

Holger J Schünemann

1 reference

18 August 2017

8

Christopher T Sempos

1 reference

18 August 2017

Franco Berrino

2

1 reference

18 August 2017

Giorgio Secreto

4

1 reference

18 August 2017

Sabrina Strano

11

1 reference

18 August 2017

Paola Muti

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

10 June 2008

1 reference

Journal of the National Cancer Institute

18 August 2017

1 reference

18 August 2017

100

1 reference

18 August 2017

12

1 reference

18 August 2017

898-905

1 reference

Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Assessment of CYP1A2 activity in clinical practice: why, how, and when?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Vitamin D and breast cancer: insights from animal models

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Role of vitamins in the risk, prevention, and treatment of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Melatonin: from basic research to cancer treatment clinics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Night shift work, light at night, and risk of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Increased breast cancer risk among women who work predominantly at night

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Circadian and sleep-dependent regulation of hormone release in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Stability, precision, and near-24-hour period of the human circadian pacemaker

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Models for longitudinal data: a generalized estimating equation approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Melatonin in humans physiological and clinical studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Role of pineal gland in aetiology and treatment of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Prediction of nocturnal plasma melatonin from morning urinary measures.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Salivary and plasma measures of dim light melatonin onset (DLMO) in patients with rapid cycling bipolar disorder.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Urinary melatonin levels and breast cancer risk

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Re: Melatonin and breast cancer: a prospective study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Melatonin and breast cancer: a prospective study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Serum sex hormone levels after menopause and subsequent breast cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

A comparison of overnight and 24 hour collection to measure urinary catecholamines

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630389

Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol

4 September 2018

1 reference

12 December 2020

The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels

1 reference

12 December 2020

[Serum creatinine determination without protein precipitation]

1 reference

12 December 2020

Radioimmunological Determination of Urinary Melatonin in Humans: Correlation with Plasma Levels and Typical 24-Hour Rhythmicity*

1 reference

12 December 2020

Urinary melatonin levels in human breast cancer patients

1 reference

12 December 2020

Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors

1 reference

12 December 2020

6-Sulphatoxymelatonin Production in Breast Cancer Patients

1 reference

12 December 2020

Plasma melatonin in patients with breast cancer

1 reference

12 December 2020

Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism

1 reference

12 December 2020

Morning urinary assessment of nocturnal melatonin secretion in older women

1 reference

12 December 2020

Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJN171

1 reference

18 August 2017

1 reference

18 August 2017

1 reference